Johnson and Johnson accepts 2.1 billion dollar offer for its LifeScan unit
Johnson and Johnson said on Tuesday it has accepted private equity firm Platinum Equity’s $2.1 billion buyout offer for the company’s LifeScan Inc unit.
Platinum had given J&J until mid-June to accept the offer for the unit, which makes blood glucose monitoring products.
(Reporting by Uday Sampath in Bengaluru; Editing by Shailesh Kuber)
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd